Terns Pharmaceutical

Developer of therapies for treating liver disease and cancer

placeSan Mateo, California, United States calendar_todayFounded 2017 groups46 employees language ternspharma.com

Registered entities

Social engagement

Social engagement: 12.2K social following, 10 posts in the last 12 months — above the industry median.

Investor mix

8 investors on record; lead investors include Vivo Capital, Orbimed, Lilly Asia Ventures, Deerfield.

Investor typeCountShare
Venture capital338%
Private equity113%
Bank & private debt113%
Other / undisclosed338%

Recent activity

29 Apr 2026
Recognition
28 Apr 2026
Milestone
regulatory
11 Mar 2026
Event
firesidechat during the 2026 Citizens Life Sciences Conference
Coming soon